Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.13%19.03B | -6.26%19.45B | -4.78%4.71B | -10.23%5.01B | -10.88%4.75B | 1.77%4.98B | 7.67%20.75B | 0.16%4.94B | 8.94%5.58B | 16.12%5.33B |
| Cost of revenue | -3.22%14.87B | -9.92%15.37B | -7.47%3.75B | -14.33%3.94B | -15.41%3.73B | -1.28%3.95B | 10.77%17.06B | -1.31%4.05B | 12.69%4.59B | 21.35%4.41B |
| Gross profit | 1.96%4.16B | 10.64%4.08B | 7.51%955.33M | 8.97%1.07B | 10.81%1.02B | 15.42%1.03B | -4.71%3.69B | 7.44%888.6M | -5.73%982.41M | -3.68%922.51M |
| Operating expense | 3.31%3.41B | -6.53%3.3B | -6.12%761.09M | -6.13%821.64M | -4.48%864.29M | -9.21%853.87M | -4.34%3.53B | -19.74%810.73M | -8.56%875.27M | 11.13%904.83M |
| Operating profit | -3.78%747.52M | 403.70%776.9M | 149.46%194.23M | 132.33%248.93M | 793.52%157.97M | 462.77%175.76M | -12.42%154.24M | 142.53%77.86M | 26.08%107.15M | -87.69%17.68M |
| Net non-operating interest income (expenses) | -32.54%-32.17M | 27.23%-24.27M | 45.72%-4.47M | 33.39%-5.7M | 17.65%-6.87M | 11.99%-7.24M | -32.49%-33.36M | -15.35%-8.24M | -12.43%-8.56M | -51.48%-8.34M |
| Non-operating interest income | -11.46%1.37M | 362.57%1.55M | 763.76%989K | -77.40%94K | 523.88%418K | --44K | 71.28%334K | -361.40%-149K | 185.07%416K | -88.91%67K |
| Non-operating interest expense | 29.91%33.54M | -23.36%25.82M | -32.49%5.46M | -35.43%5.8M | -13.33%7.28M | -11.46%7.28M | 32.79%33.69M | 12.36%8.09M | 25.98%8.98M | 37.60%8.4M |
| Net investment income | -34.77%9.8M | -79.64%15.02M | 45.01%-18.78M | -68.92%22.34M | -82.19%5.07M | -15.87%6.39M | 106.39%73.79M | -1,166.98%-34.15M | 381.50%71.87M | 204.98%28.47M |
| Gain(Loss) on financial instruments designated as cash flow hedges | -97.39%17.95M | 231.78%688.49M | -95.20%5.1M | 102.29%16.01M | 58.68%111.8M | 555.59M | -1,049.95%-522.44M | 251.35%106.14M | -4,086.09%-699.04M | 348.15%70.45M |
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | 30.51%3.74M | 0 | 0 | 0 | |||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 98.43%-1.14M | 95.64%-72.62M | 84.45%-258.99M | -318,700.00%-3.19M | 2,846,500.00%199.26M | -970,500.00%-9.7M | -281,464.70%-1.67B | -11,103.16%-1.67B | 99.79%-1K | 7K |
| Less:Other special charges | 101.34%2.71M | -2,052.20%-202.48M | -99.78%23K | --1.33M | ---203.83M | ---10K | 1,852.03%10.37M | -30.19%10.38M | --0 | ---- |
| Less:Write off | -100.57%-1.57M | -83.38%275.1M | -84.36%258.97M | 185,600.00%1.86M | --4.56M | 971,500.00%9.71M | --1.66B | --1.66B | --1K | --0 |
| Other non-operating income (expenses) | -29.27%2.85M | -54.84%4.02M | -189.92%-4.48M | 2,838.89%1.97M | 169.21%6.53M | -100.13%-2K | 111.70%8.91M | 67.53%4.98M | -102.86%-72K | -44.05%2.43M |
| Income before tax | -46.32%744.8M | 170.05%1.39B | 94.25%-87.39M | 153.03%280.36M | 327.99%473.77M | 1,747.34%720.79M | -1,272.16%-1.98B | -784.57%-1.52B | -572.58%-528.66M | -39.66%110.7M |
| Income tax | -26.68%277.45M | 204.12%378.41M | 108.96%42.63M | -24.11%88.86M | 122.54%101.75M | 387.93%145.17M | -450.44%-363.45M | -2,635.54%-475.85M | 123.24%117.09M | -4.56%45.72M |
| Net income | -53.69%467.35M | 162.39%1.01B | 87.54%-130.02M | 129.66%191.51M | 472.57%372.01M | 8,539.10%575.62M | -2,577.82%-1.62B | -575.95%-1.04B | -1,186.81%-645.75M | -52.06%64.97M |
| Net income continuous operations | -53.69%467.35M | 162.39%1.01B | 87.54%-130.02M | 129.66%191.51M | 472.57%372.01M | 8,539.11%575.62M | -2,577.82%-1.62B | -575.95%-1.04B | -1,186.80%-645.75M | -52.07%64.97M |
| Noncontrolling interests | 0 | 0 | ||||||||
| Net income attributable to the company | -53.69%467.35M | 162.39%1.01B | 87.54%-130.02M | 129.66%191.51M | 472.57%372.01M | 8,539.10%575.62M | -1,911.00%-1.62B | -708.87%-1.04B | -1,211.65%-645.75M | -52.06%64.97M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -53.69%467.35M | 162.39%1.01B | 87.54%-130.02M | 129.66%191.51M | 472.57%372.01M | 8,539.10%575.62M | -1,911.00%-1.62B | -708.87%-1.04B | -1,211.65%-645.75M | -52.06%64.97M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -53.69%60.48 | 162.39%130.59 | 87.53%-16.83 | 129.65%24.78 | 472.53%48.15 | 8,561.63%74.49 | -1,910.55%-209.3 | -708.87%-135 | -1,211.30%-83.57 | -52.05%8.41 |
| Diluted earnings per share | -53.69%60.48 | 162.39%130.59 | 87.53%-16.83 | 129.65%24.78 | 472.57%48.1429 | 8,561.63%74.49 | -1,910.55%-209.3 | -708.87%-135.0072 | -1,211.83%-83.57 | -52.06%8.4083 |
| Dividend per share | 0.00%20 | 0.00%20 | 0.00%20 | 0 | 0 | 0 | 0.00%20 | 0.00%20 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |